Muscle GLUT4 in cirrhosis

Journal of Hepatology

Volumn 47, Issue 2, 2007, Pages 212-219

  Holland Fischer, Peter ^a   Andersen, Per Heden ^a,b   Lund, Sten ^a   Pedersen, Steen Bønnelykke ^a   Vinter Jensen, Lars ^a   Nielsen, Michael F ^a   Kaal, Andreas ^a   Dall, Rolf ^a   Schmitz, Ole ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Clinical research; Glucose intolerance; GLUT4; Insulin resistance; Liver cirrhosis; Skeletal muscle

Indexed keywords

GLUCOSE TRANSPORTER 4;

ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; LIVER CIRRHOSIS; MALE; MUSCLE BIOPSY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; FEMALE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPERINSULINISM; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RNA, MESSENGER;

EID: 34347376699     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.02.012     Document Type: Article

References (44)

1. Kasperska-Czyzykowa T., Heding L.G., and Czyzyk A. Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis. Diabetologia 25 (1983) 506-509
2. Shmueli E., Record C.O., and Alberti K.G. Liver disease, carbohydrate metabolism and diabetes. Baillieres Clin Endocrinol Metab 6 (1992) 719-743
3. Selberg O., Bottcher J., Tusch G., Pichlmayr R., Henkel E., and Muller M.J. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25 (1997) 652-657
4. Cavallo-Perin P., Cassader M., Bozzo C., Bruno A., Nuccio P., Dall'omo A.M., et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest 75 (1985) 1659-1665
5. Iversen J., Vilstrup H., and Tygstrup N. Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology 87 (1984) 1138-1143
6. Petrides A.S., and DeFronzo R.A. Glucose and insulin metabolism in cirrhosis. J Hepatol 8 (1989) 107-114
7. Selberg O., Burchert W., vd H.J., Meyer G.J., Hundeshagen H., Radoch E., et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 91 (1993) 1897-1902
8. Petersen K.F., Krssak M., Navarro V., Chandramouli V., Hundal R., Schumann W.C., et al. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol 276 (1999) E529-E535
9. Petrides A.S., Groop L.C., Riely C.A., and DeFronzo R.A. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest 88 (1991) 561-570
10. Cavallo-Perin P., Cassader M., Bozzo C., Bruno A., Nuccio P., Dall'omo A.M., et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest 75 (1985) 1659-1665
11. Nielsen M.F., Caumo A., Aagaard N.C., Chandramouli V., Schumann W.C., Landau B.R., et al. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: Assessment during physiologic glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol (2005)
12. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., and Felber J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981) 1000-1007
13. Lund S., Holman G.D., Zierath J.R., Rincon J., Nolte L.A., Clark A.E., et al. Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique. Diabetes 46 (1997) 1965-1969
14. Zisman A., Peroni O.D., Abel E.D., Michael M.D., Mauvais-Jarvis F., Lowell B.B., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6 (2000) 924-928
15. Cline G.W., Petersen K.F., Krssak M., Shen J., Hundal R.S., Trajanoski Z., et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341 (1999) 240-246
16. Ren J.M., Marshall B.A., Gulve E.A., Gao J., Johnson D.W., Holloszy J.O., et al. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268 (1993) 16113-16115
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28:S37-42.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Andersen P.H., Lund S., Schmitz O., Junker S., Kahn B.B., and Pedersen O. Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT4 mRNA, GLUT4 protein and fibre type composition of skeletal muscle. Acta Physiol Scand 149 (1993) 393-404
20. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
21. Labarca C., and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102 (1980) 344-352
22. Buhl E.S., Jessen N., Schmitz O., Pedersen S.B., Pedersen O., Holman G.D., et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50 (2001) 12-17
23. Lund S., Flyvbjerg A., Holman G.D., Larsen F.S., Pedersen O., and Schmitz O. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol 267 (1994) E461-E466
24. Andersen L., Dinesen B., Jorgensen P.N., Poulsen F., and Roder M.E. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39 (1993) 578-582
25. Heding L.G. Radioimmunological determination of human C-peptide in serum. Diabetologia 11 (1975) 541-548
26. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 18 (1966) 118-125
27. Lukaski H.C., Johnson P.E., Bolonchuk W.W., and Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41 (1985) 810-817
28. Kruszynska Y., Williams N., Perry M., and Home P. The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Hepatology 8 (1988) 1615-1619
29. Kruszynska Y.T., Harry D.S., Bergman R.N., and McIntyre N. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia 36 (1993) 121-128
30. Andersen P.H., Lund S., Vestergaard H., Junker S., Kahn B.B., and Pedersen O. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77 (1993) 27-32
31. Andersen P.H., Vestergaard H., Lund S., Vedel P., Junker S., Kahn B.B., et al. The effect of intensive insulin therapy on the insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes. Diabet Med 10 (1993) 699-706
32. Houmard J.A., Weidner M.D., Dolan P.L., Leggett-Frazier N., Gavigan K.E., Hickey M.S., et al. Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 44 (1995) 555-560
33. Garvey W.T., Maianu L., Hancock J.A., Golichowski A.M., and Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41 (1992) 465-475
34. Pedersen O., Bak J.F., Andersen P.H., Lund S., Moller D.E., Flier J.S., et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39 (1990) 865-870
35. Dela F., Ploug T., Handberg A., Petersen L.N., Larsen J.J., Mikines K.J., et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 43 (1994) 862-865
36. Kraniou G.N., Cameron-Smith D., and Hargreaves M. Effect of short-term training on GLUT-4 mRNA and protein expression in human skeletal muscle. Exp Physiol 89 (2004) 559-563
37. Kraniou Y., Cameron-Smith D., Misso M., Collier G., and Hargreaves M. Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol 88 (2000) 794-796
38. O'Brien R.M., and Granner D.K. Regulation of gene expression by insulin. Physiol Rev 76 (1996) 1109-1161
39. Flores-Riveros J.R., McLenithan J.C., Ezaki O., and Lane M.D. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci USA 90 (1993) 512-516
40. Jessen N., Buhl E.S., Schmitz O., and Lund S. Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis. J Hepatol 45 (2006) 797-804
41. Merli M., Leonetti F., Riggio O., Valeriano V., Ribaudo M.C., Strati F., et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 30 (1999) 649-654
42. Petrides A.S., Stanley T., Matthews D.E., Vogt C., Bush A.J., and Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 28 (1998) 141-149
43. Shmueli E., Orskov H., Alberti K.G., and Record C.O. Octreotide treatment does not improve impaired glucose uptake in cirrhosis. Horm Metab Res 25 (1993) 317-320
44. Ryder J.W., Yang J., Galuska D., Rincon J., Bjornholm M., Krook A., et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49 (2000) 647-654